Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions
Iva Brčić(Medical University of Graz), Bernadette Liegl‐Atzwanger(Medical University of Graz), Herwig Lackner(Medical University of Graz), Theresa Godschachner(Medical University of Graz), Karl Kashofer(Medical University of Graz), Holger Till(University Hospital Leipzig), Joanna Szkandera(Medical University of Graz), Marko Bergovec(Medical University of Graz), Andreas Leithner(Medical University of Graz), Susanne Scheipl(Medical University of Graz), Thomas Brodowicz(Comprehensive Cancer Center Vienna), Jasminka Igrec(Medical University of Graz)
Cited by 99
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication
|Brain Behavior and Immunity|2016|741
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2021|558
Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cells
|Transfusion|2007|507
Inferring expressed genes by whole-genome sequencing of plasma DNA
|Nature Genetics|2016|463